Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Ambovex® 作为一种新型免疫调节剂药物，用于治疗肝脏中的肝细胞癌 (HCC)：一项 II 期临床试验
期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S60864
Salama, Hosny; Ahmad, Hassan; Elchagea, Ismail; Zekri, Abdel Rahman; Medhat, Eman; Bahnassy, Abeer; Lange, Michael; Rabbat, Mohammed; de la Torre, Andrew N; Punamiya, Pravin
